Preeminent researcher leading largest prospective, multi-trail COVID studies in U.S. and first ever clinical investigation on potential COVID-microbiome connection

16-Sep-2020 7:05 AM EDT, by Weber Shandwick, Chicago

Media Briefing Opportunity: Preeminent researcher leading largest prospective, multi-trail COVID studies in U.S. and first ever clinical investigation on potential COVID-microbiome connection

Why do some people have severe reactions to COVID whereas others do not?  Are there overlooked or unexplained factors in how people respond to the COVID virus connected to their gut microbiome? Could microbiome predict the severity of illness among those exposed to the virus?

Those are just a few of the questions being explored in a first-of-its-kind, clinical investigations being led by Martin Blaser, M.D., one of world’s preeminent experts on the human microbiome, immunity and chronic diseases. Dr. Blaser, professor of medicine and microbiology at the Robert Wood Johnson Medical School and director of Rutgers University’s Center for Advanced Biotechnology and Medicine, is author of the global, best-selling book Missing Microbes: How the Overuse of Antibiotics is Fueling Our Modern Plagues (he predicted a pandemic in this book). He has conducted numerous studies demonstrating the role of the microbiome to immunity and diseases and now exploring if there is a potential connection with COVID.  In June 2020, Dr. Blaser and colleagues at Rutgers and the Cleveland Clinic began research into the potential microbiome-COVID connection as part of the United States’ largest prospective, multi-trail study of those exposed to COVID-19, including hundreds of healthcare workers enrolled in the study.    

On Wednesday, September 23rd from 1:30-2:00 PM ET, Dr. Blaser will provide an exclusive look at the studies underway, more about his hypothesis on the microbiome-disease connection and share other initial insights from the broader COVID study. This invitation-only briefing will be hosted by Miguel Freitas, Ph.D., vice president of health and scientific affairs at Danone North America. (Danone is a research funder, but the research does not involve their products nor involvement in study design).  Dr. Blaser will answer questions during the briefing and/or attendees can request advance or follow-up information.

 

To register to participate in this invitation-only briefing and for additional information, contact Michael Schiferl, Executive Vice President, Weber Shandwick at mschiferl@webershandwick.com.  Attendees will receive instructions for virtual attendance upon confirmed interest.       

 




Filters close

Showing results

110 of 3409
Newswise: Last-resort life support option helped majority of critically ill COVID-19 patients survive, global study shows
24-Sep-2020 3:20 PM EDT
Last-resort life support option helped majority of critically ill COVID-19 patients survive, global study shows
Michigan Medicine - University of Michigan

It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it. Patients in a new international study faced a staggeringly high risk of death, as ventilators failed to support their lungs. But after they were placed on ECMO, their actual death rate was less than 40%.

Released: 25-Sep-2020 5:05 PM EDT
Case Western Reserve University researchers to examine how COVID-19 ravaged America’s nursing homes
Case Western Reserve University

Within a few months, federal officials reported that one of every five nursing homes had experienced a death from the novel coronavirus. Not long after, several media outlets published independent analysis finding that an estimated 40% of the fatalities related to COVID-19 took place in nursing homes. Rather than surrender to the terrifying trend, Case Western Reserve researchers saw an opportunity to help.

Released: 25-Sep-2020 4:15 PM EDT
Faced with pandemic shortages, researchers combine heat and humidity to disinfect N95 masks for reuse
SLAC National Accelerator Laboratory

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

Released: 25-Sep-2020 3:30 PM EDT
Team assessing if dual-antibody injection prevents COVID-19 illness
University of Texas Health Science Center at Houston

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.

Released: 25-Sep-2020 2:30 PM EDT
Yes, Wisconsin Republicans have the power to overturn the extended mask mandate order by Governor Evers
Newswise

Republicans have the legal power to reverse the order by Wisconsin Governor Tony Evers that extends the mask mandate.

Released: 25-Sep-2020 1:55 PM EDT
How do Americans view the virus? Anthropology professor examines attitudes of COVID
Northern Arizona University

In her ongoing research about Americans' responses to the COVID-19 pandemic, Northern Arizona University anthropology professor Lisa Hardy and her collaborators have talked to dozens of people.

Released: 25-Sep-2020 12:55 PM EDT
During pandemic, racism puts additional stress on Asian Americans
Massachusetts General Hospital

Many people are feeling anxious during these uncertain times as they navigate the risks associated with COVID-19 and experience the tension from physical distancing or isolation for what can seem like an eternity.

Released: 25-Sep-2020 12:55 PM EDT
COVID-19 shapes political approval ratings
University of North Carolina at Chapel Hill

Approval ratings of political leaders surged in the early days of the COVID-19 pandemic, according to a new study published in the Proceedings of the National Academy of Sciences.

Released: 25-Sep-2020 12:40 PM EDT
ASU Researchers Receive $6m State Contract to Develop Rapid, 20-Minute Covid-19 Saliva Test
Arizona State University (ASU)

As the world manages through the coronavirus pandemic, Arizona State University continues its work to discover and develop easier and more widespread COVID-19 testing to assist in managing the virus.

Released: 25-Sep-2020 11:55 AM EDT
Scholars untangle marketing's complex role in understanding political activities
American Marketing Association (AMA)

As 2020 began, many pundits predicted a politically charged year, but few predicted that it would include a global pandemic overtaxing healthcare resources, strained U.S. race relations resulting in mass demonstrations across the globe, devastating fires consuming massive swaths of the United States, and a catastrophic global economic downturn.


Showing results

110 of 3409

close
0.7793